Business news for Danaher Corporation (DHR), a science technology firm, ranges from articles on the company's stock price fluctuation to strategic partnerships. The company's shares valued at US$238 raise a significant interest in the investment sphere, with large amounts of shares being continuously bought by various entities like ORG Partners LLC, Douglas Lane & Associates LLC, and Nordea Investment Management AB. In its attempt to revolutionize healthcare via AI, Danaher is partnering with Innovaccer. Meanwhile, the company schedules its Q4 2024 earnings call this January 29, and its Q3 2024 earnings outlines a robust performance amidst market woes. The projected intrinsic value of Danaher is also drawing the attention of investors. On another note, Danaher has purchased an AI Healthcare Company, and its Strategic SWOT insight is made available. Lastly, potential red flags include a report stating a high single-digit percent drop in China's core revenue and criticism over lackluster performance and guidance.
Danaher Corporation DHR News Analytics from Tue, 23 Apr 2024 07:00:00 GMT to Sat, 11 Jan 2025 09:12:17 GMT - Rating 4 - Innovation 1 - Information 7 - Rumor -1
